Drug Shortage Report for TRANDATE

Last updated on 2024-11-13 History
Report ID 242860
Drug Identification Number 02106272
Brand name TRANDATE
Common or Proper name Trandate 100mg
Company Name PALADIN PHARMA INC.
Market Status MARKETED
Active Ingredient(s) LABETALOL HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 tabs
ATC code C07AG
ATC description BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-11-08
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2024-11-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 100 BLVD ALEXIS-NIHON, SUITE 600
MONTREAL, QUEBEC
CANADA H4M 2P2
Company contact information 1-866-340-1112 paladincs@endo.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2024-11-13 French Compare
v1 2024-11-13 English Compare

Showing 1 to 2 of 2